A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK

Abstract Introduction High‐dose methotrexate (HDMTX) is administered for the treatment of some malignancies. Serious complications after the administration of HDMTX are rare, but occasionally MTX may precipitate in the renal tubes causing a delayed elimination leading to renal, multiorgan toxicities...

Descripción completa

Detalles Bibliográficos

Autores principales:	Stefan Bielack, Christopher P. Fox, Khê Hoang‐Xuan, Ariadna Giró‐Perafita, Carmelo Rizzari
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2024-01-01
Colección:	Health Science Reports
Materias:	acute kidney injury (AKI) epidemiology high‐dose methotrexate (HDMTX) methotrexate delayed elimination MTX toxicity clinical management
Acceso en línea:	https://doi.org/10.1002/hsr2.1749
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!